Business Context and Reporting Period
This Form 8-K Current Report was filed by Matinas Biopharma Holdings, Inc. on February 22, 2019, covering events occurring on February 25, 2019. The Company is an emerging growth company incorporated in Delaware, focused on biopharmaceuticals.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on executive compensation and appointment details.
Material Changes
The primary material change reported is the appointment of James J. Ferguson III as Chief Medical Officer, effective February 25, 2019. Dr. Ferguson joins from Amgen Inc., where he served as an Executive Director from 2016 to 2019.
Management Commentary and Compensation Details
The Company entered into an employment agreement with Dr. Ferguson containing the following terms:
- Sign-on Bonus: One-time payment of $50,000.
- Base Salary: Initial annual salary of $375,000.
- Annual Bonus: Target amount of up to 35% of base salary, contingent on performance targets.
- Equity Grant: Options to purchase 350,000 shares of common stock under the 2013 Equity Incentive Plan.
- Severance: In the event of termination "without cause" or resignation for "good reason," Dr. Ferguson is entitled to 12 months of base salary, 12 months of COBRA benefits, and 50% acceleration of outstanding equity awards, subject to a release agreement.
The filing includes a press release regarding this appointment as Exhibit 99.1, which is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the vesting schedule for the 350,000 stock options granted to Dr. Ferguson.
- Review the specific performance targets required to achieve the 35% annual bonus.
- Confirm the total number of outstanding equity awards held by Dr. Ferguson to calculate the value of the 50% acceleration clause in a severance scenario.
- Check the Company's cash position to assess the impact of the $50,000 sign-on bonus and future salary obligations.